Standard Biotools (LAB) Net Cash Flow Growth (5y) (2015 - 2026)
Standard Biotools (LAB) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.67 Bn | 194.07 Bn | 7.27 Bn |
| 2 | Stryker | 129.56 Bn | 126.09 Bn | 4.50 Bn |
| 3 | Medtronic | 119.87 Bn | 110.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.80 Bn | 73.27 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.66 Bn | 48.41 Bn | 1.35 Bn |
| 6 | Dexcom | 34.56 Bn | 32.61 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Standard Biotools | 258.10 Mn | -218.62 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.05% |
| Mar 31, 2026 | 57.41% |
| Dec 31, 2025 | -15.87% |
| Sep 30, 2025 | -24.56% |
| Jun 30, 2025 | -2.41% |
| Mar 31, 2025 | -26.51% |
| Dec 31, 2024 | -58.48% |
| Sep 30, 2024 | -102.77% |
| Jun 30, 2024 | 15.37% |
| Mar 31, 2024 | 58.27% |
| Dec 31, 2023 | -19.87% |
| Sep 30, 2023 | -78.99% |
| Jun 30, 2023 | 71.75% |
| Mar 31, 2023 | 31.60% |
| Dec 31, 2022 | 54.65% |
| Sep 30, 2022 | -21.53% |
| Jun 30, 2022 | 62.75% |
| Mar 31, 2022 | -29.08% |
| Sep 30, 2021 | -62.61% |
| Jun 30, 2021 | -40.40% |